ENDRA Life Sciences Inc. (NDRA): Shareholders' Equity
$2.26M
As of 2025-12-31
$6.31M
As of 2026-06-30
-32.1%
3-year compound annual growth
-20.6%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.26M | -11.7% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $2.56M | -54.8% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $5.66M | -21.5% | 2025-04-07, Balance as of period end |
| 2022-12-31 | $7.20M | -33.2% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $10.78M | +50.4% | 2023-03-16, Balance as of period end |
| 2020-12-31 | $7.17M | +50.6% | 2022-03-30, Balance as of period end |
| 2019-12-31 | $4.76M | -23.8% | 2021-03-25, Balance as of period end |
| 2018-12-31 | $6.25M | +18.4% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $5.28M | n/m | 2019-03-11, Balance as of period end |
| 2016-12-31 | -$893.8K | n/a | 2018-03-20, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | 2025-12-31 | $2.26M | -11.7% |
| Positron Corp (POSC) | 2025-12-31 | $1.44M | n/m |
| Nexalin Technology, Inc. (NXL) | 2025-12-31 | $3.75M | +2.0% |
| Escalon Medical Corp (ESMC) | 2025-06-30 | $1.92M | +5.8% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $2.62M | -59.8% |
| Neuraxis, Inc (NRXS) | 2025-12-31 | $3.40M | +64.4% |
| ADM Tronics Unlimited, Inc. (ADMT) | 2026-03-31 | $571.0K | -15.0% |
| iTonic Holdings Ltd (ITOC) | 2025-12-31 | $6.12M | -1.0% |
| Guided Therapeutics Inc (GTHP) | 2025-12-31 | -$6.01M | n/m |
Compare NDRA, POSC, NXL, ESMC side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗